🔎 Trials Near Me

Gara Jalqabaatti › Sklerosis Baay’ee › Massachusetts

Qorannoo klinikaalii Sklerosis Baay’ee Massachusetts keessatti

Qorannoo 18 Sklerosis Baay’ee f Massachusetts keessatti hirmaatuu jiru.

Magaalota Massachusetts keessatti

Takkalaa qorannoo (Ingiliffa)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • Neurology Center of New England, Foxborough
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06782490

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Boston
  • TG Therapeutics Investigational Trial Site, Burlington
  • TG Therapeutics Investigational Trial Site, Norfolk
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Dana Farber Cancer Institute, Boston
  • University of Massachusetts Chan Medical Center, Worcester
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07002034

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Neuro Institute of New England P C, Foxborough
  • Elliot Lewis MS Center, Wellesley
  • U Mass Memorial Medical Center, Worchester
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT07225504

Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis

  • MGH Institute of Health Professions, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 25 hanga 75 · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT06136728

Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

  • Beth Israel Deaconess Medical Center, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT04603196

Care in Multiple Sclerosis (MS)

  • Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT07011914

Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • Brigham MS Center, 60 Fenwood Road, Boston
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 02-Gur-2026 · NCT03207464

PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases

  • Brigham MS Center, 60 Fenwood Road, Boston
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 28-Ama-2026 · NCT02649985

Glucose Consumption in MS Using [F-18]FDG-PET

  • Brigham & Women's Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 4Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 09-Ama-2026 · NCT07087106

Assessment of Synaptic Density in MS

  • Brigham and Women's Hospital, Boston
Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 09-Ama-2026 · NCT04634994

Efgartigimod for the Treatment of Acute Optic Neuritis

  • Massachusetts Eye and Ear Infirmary, Boston
  • Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Sad-2025 · NCT06453694

Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension

  • UMass Boston, Boston
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Hag-2025 · NCT06554340

Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis

  • Brigham and Women's Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 06-Wax-2025 · NCT06890923

Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects

  • Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 27-Gur-2025 · NCT04699747

IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis

  • Accelerated Cure Project, Waltham
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin hundi · Saalaa hunda · Haaromfame 18-Gur-2025 · NCT02486562

A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

  • Neurology Center of New England P.C., Foxborough
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 55 hanga 80 · Saalaa hunda · Haaromfame 18-Sad-2024 · NCT06681623

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.